Investors / United States / Magnetic Ventures
Magnetic Ventures
Venture capital · United States · North America
Magnetic Ventures is a venture capital firm that invests in early-stage life science companies applying deep technology. It provides hands-on support to founders from seed through the company lifecycle.
Invests inHealthcare & Biotech
In its own wordslife sciencesdeep techartificial intelligencemachine learningdrug discoveryprecision medicine
Your fit with Magnetic Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsMagnetic Ventures lists 13 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (86%) and Media & Entertainment (14%). 89% of its companies are based in United States. It invests most often alongside ARCH Venture Partners, DCVC and F-Prime Capital.
No funding round on record names Magnetic Ventures yet, so the figures come from its portfolio page.
Round figures show recent activity, not Magnetic Ventures' whole history. Rounds on record name 0 companies; its own site lists 13. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 33th | 13 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 94th | 86% in its largest sector |
| Reach | 42th | 2 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers13100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 86% | 15% |
| Media & Entertainment | 14% | 4% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with ARCH Venture Partners
Compare Magnetic Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
13 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| AppliedVR combines immersive technology with therapeutic techniques to create healthcare solutions. | Healthcare & BiotechMedia & Entertainment | Portfolio page | ||
| Deep Genomics develops genetic medicines using artificial intelligence | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Gilgamesh Pharma develops innovative new chemical entities to transform the treatment paradigm of psychiatric disease | Healthcare & Biotech | Portfolio page | ||
| HiberCell develops therapeutic candidates to target the integrated stress response in cancer treatment. | Healthcare & Biotech | Portfolio page | ||
| Paradigm Health provides a platform for clinical trials, offering solutions for trial sponsors and research sites | Healthcare & Biotech | Portfolio page | ||
| Proxima makes protein interactions programmable to unlock a new chapter in medicine | Healthcare & Biotech | Portfolio page | ||
| The company develops medicines through its platform that determines the biology to prosecute with confidence. | Healthcare & Biotech | Portfolio page | ||
| Resilience provides contract development and manufacturing services for biologics and sterile drug products | Healthcare & BiotechMedia & Entertainment | Portfolio page | ||
| Stipple Bio develops life-changing medicines for people with cancer using a precision-driven approach to oncology. | Healthcare & Biotech | Portfolio page | ||
| Transition Bio develops drugs using a platform that combines droplet microfluidics and cellular imaging with machine learning and artificial intelligence. | Healthcare & Biotech | Portfolio page | ||
| Triveni Bio is a clinical-stage biotech company taking a genetics-informed approach and leveraging advanced antibody engineering to build first-in-class therapeutics for immune and inflammatory diseases. | Healthcare & Biotech | Portfolio page | ||
| Weave Bio connects source data, documents, and teams in real time to facilitate drug development | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- magneticvc.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 13
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Magnetic Ventures' profile as data
Pull Magnetic Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/magneticvc.com
# also
GET /v1/firms/magneticvc.com/portfolio
GET /v1/firms/magneticvc.com/coinvestors
GET /v1/firms/magneticvc.com/news